Page last updated: 2024-08-18

quinuclidines and Cancer of Gastrointestinal Tract

quinuclidines has been researched along with Cancer of Gastrointestinal Tract in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hashimoto, H; Murakami, M; Senba, S; Siraishi, T; Yamaguchi, I; Yamaguchi, K	1
Bekaii-Saab, T; Blazer, M; Efries, D; Griffith, N; Juergens, K; Phillips, G; Reardon, J; Rose, J; Smith, Y; Weatherby, L	1
Ihbe-Heffinger, A; Lordick, F; Peschel, C	1

Reviews

1 review(s) available for quinuclidines and Cancer of Gastrointestinal Tract

Article	Year
[Antiemetic prophylaxis in the chemotherapy of gastrointestinal tumours]. Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:4 Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Drug Therapy, Combination; Gastrointestinal Neoplasms; Humans; Isoquinolines; Morpholines; Nausea; Palonosetron; Premedication; Quinuclidines; Treatment Outcome; Vomiting	2005

Article

Year

[Antiemetic prophylaxis in the chemotherapy of gastrointestinal tumours].

Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:4

Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Drug Therapy, Combination; Gastrointestinal Neoplasms; Humans; Isoquinolines; Morpholines; Nausea; Palonosetron; Premedication; Quinuclidines; Treatment Outcome; Vomiting

2005

Trials

2 trial(s) available for quinuclidines and Cancer of Gastrointestinal Tract

Article	Year
Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Surveys and Questionnaires; Vomiting	2014
Antiemetic control with palonosetron in patients with gastrointestinal cancer receiving a fluoropyrimidine-based regimen in addition to either irinotecan or oxaliplatin: a retrospective study. Oncology, 2012, Volume: 83, Issue:3 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Deoxycytidine; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Irinotecan; Isoquinolines; Male; Middle Aged; Nausea; Ondansetron; Organoplatinum Compounds; Oxaliplatin; Palonosetron; Quinuclidines; Retrospective Studies; Treatment Outcome	2012

Article

Year

Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Surveys and Questionnaires; Vomiting

2014

Antiemetic control with palonosetron in patients with gastrointestinal cancer receiving a fluoropyrimidine-based regimen in addition to either irinotecan or oxaliplatin: a retrospective study.

Oncology, 2012, Volume: 83, Issue:3

Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Deoxycytidine; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Irinotecan; Isoquinolines; Male; Middle Aged; Nausea; Ondansetron; Organoplatinum Compounds; Oxaliplatin; Palonosetron; Quinuclidines; Retrospective Studies; Treatment Outcome

2012